Trial Profile
Efficacy of sunitinib in patients with metastatic renal cell carcinoma: A retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Feb 2016
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 25 Feb 2016 New trial record